IDH3A and cancer: Several key enzymes in the glycolytic pathway and tricarboxylic acid cycle, (pyruvate kinase M2, pyruvate dehydrogenase kinase, isocitrate dehydrogenase, succinate dehydrogenase, lactate dehydrogenase and others (representative articles include [9,10,11,12,13,14,15,16,17]) are targets for anti-cancer drugs.